Biblio

Found 23 results
Author Keyword Title Type [ Year(Asc)]
Filters: First Letter Of Title is A  [Clear All Filters]
2018
Nafikov RA, Nato AQ, Sohi H, Wang B, Brown L, Horimoto AR, Vardarajan BN, Barral SM, Tosto G, Mayeux RP et al..  2018.  Analysis of pedigree data in populations with multiple ancestries: Strategies for dealing with admixture in Caribbean Hispanic families from the ADSP.. Genet Epidemiol. 42(6):500-515.
2017
Crane PK, Foroud T, Montine TJ, Larson EB.  2017.  Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.. Alzheimers Dement. 13(12):1410-1413.
Beecham GW, Bis JC, Martin ER, Choi S-H, Destefano AL, van Duijn CM, Fornage M, Gabriel SB, Koboldt DC, Larson DE et al..  2017.  The Alzheimer's Disease Sequencing Project: Study design and sample selection.. Neurol Genet. 3(5):e194.
Fernández MVictoria, Kim JHun, Budde JP, Black K, Medvedeva A, Saef B, Deming Y, Del-Aguila J, Ibañez L, Dube U et al..  2017.  Analysis of neurodegenerative Mendelian genes in clinically diagnosed Alzheimer Disease.. PLoS Genet. 13(11):e1007045.
Mastroeni D, Sekar S, Nolz J, Delvaux E, Lunnon K, Mill J, Liang WS, Coleman PD.  2017.  ANK1 is up-regulated in laser captured microglia in Alzheimer's brain; the importance of addressing cellular heterogeneity.. PLoS One. 12(7):e0177814.
2016
Karch CM, Ezerskiy LA, Bertelsen S, Goate AM.  2016.  Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci.. PLoS One. 11(2):e0148717.
2015
Ghani M, Reitz C, Cheng R, Vardarajan BNarayan, Jun G, Sato C, Naj A, Rajbhandary R, San Wang L-, Valladares O et al..  2015.  Association of Long Runs of Homozygosity With Alzheimer Disease Among African American Individuals.. JAMA Neurol. 72(11):1313-23.
2014
Karch CM, Cruchaga C, Goate AM.  2014.  Alzheimer's disease genetics: from the bench to the clinic.. Neuron. 83(1):11-26.
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HSeng, Younkin C, Crook JE, V Pankratz S, Carrasquillo MM, Krishnan S et al..  2014.  Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.. Alzheimers Res Ther. 6(4):39.
2013
Ridge PG, Mukherjee S, Crane PK, Kauwe JSK.  2013.  Alzheimer's disease: analyzing the missing heritability.. PLoS One. 8(11):e79771.
Thambisetty M, An Y, Tanaka T.  2013.  Alzheimer's disease risk genes and the age-at-onset phenotype.. Neurobiol Aging. 34(11):2696.e1-5.
Lin C-F, Naj AC, San Wang L-.  2013.  Analyzing copy number variation using SNP array data: protocols for calling CNV and association tests.. Curr Protoc Hum Genet. 79:Unit1.27..
2012
Swaminathan S, Huentelman MJ, Corneveaux JJ, Myers AJ, Faber KM, Foroud T, Mayeux R, Shen L, Kim S, Turk M et al..  2012.  Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. PLoS One. 7(12):e50640.
2011
Kramer PL, Xu H, Woltjer RL, Westaway SK, Clark D, Erten-Lyons D, Kaye JA, Welsh-Bohmer KA, Troncoso JC, Markesbery WR et al..  2011.  Alzheimer disease pathology in cognitively healthy elderly: a genome-wide study.. Neurobiol Aging. 32(12):2113-22.
2010
Reynolds CA, Hong M-G, Eriksson UK, Blennow K, Wiklund F, Johansson B, Malmberg B, Berg S, Alexeyenko A, Grönberg H et al..  2010.  Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.. Hum Mol Genet. 19(10):2068-78.
Corneveaux JJ, Myers AJ, Allen AN, Pruzin JJ, Ramirez M, Engel A, Nalls MA, Chen K, Lee W, Chewning K et al..  2010.  Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals.. Hum Mol Genet. 19(16):3295-301.
2008
Lee JH, Barral S, Cheng R, Chacon I, Santana V, Williamson J, Lantigua R, Medrano M, Jimenez-Velazquez IZ, Stern Y et al..  2008.  Age-at-onset linkage analysis in Caribbean Hispanics with familial late-onset Alzheimer's disease.. Neurogenetics. 9(1):51-60.
Lee JH, Cheng R, Graff-Radford N, Foroud T, Mayeux R.  2008.  Analyses of the National Institute on Aging Late-Onset Alzheimer's Disease Family Study: implication of additional loci.. Arch Neurol. 65(11):1518-26.
2006
Murrell JR, Price B, Lane KA, Baiyewu O, Gureje O, Ogunniyi A, Unverzagt FW, Smith-Gamble V, Gao S, Hendrie HC et al..  2006.  Association of apolipoprotein E genotype and Alzheimer disease in African Americans.. Arch Neurol. 63(3):431-4.
2005
Nowotny P, Hinrichs AL, Smemo S, Kauwe JSK, Maxwell T, Holmans P, Hamshere M, Turic D, Jehu L, Hollingworth P et al..  2005.  Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.. Am J Med Genet B Neuropsychiatr Genet. 136B(1):62-8.
2004
Busby V, Goossens S, Nowotny P, Hamilton G, Smemo S, Harold D, Turic D, Jehu L, Myers A, Womick M et al..  2004.  Alpha-T-catenin is expressed in human brain and interacts with the Wnt signaling pathway but is not responsible for linkage to chromosome 10 in Alzheimer's disease.. Neuromolecular Med. 5(2):133-46.
van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, Saunders AM, Roses AD, Small GW et al..  2004.  Analysis of European mitochondrial haplogroups with Alzheimer disease risk.. Neurosci Lett. 365(1):28-32.
1996
Kukull WA, Schellenberg GD, Bowen JD, McCormick WC, Yu CE, Teri L, Thompson JD, O'Meara ES, Larson EB.  1996.  Apolipoprotein E in Alzheimer's disease risk and case detection: a case-control study.. J Clin Epidemiol. 49(10):1143-8.